Differentiated Thyroid Cancer Genetic Mechanisms – Focus on Vitamin D Receptor and Methylenetetrahydrofolate Reductase Gene Polymorphisms
Thyroid cancer is the most frequent endocrine cancer representing 1-1.5% of all cancers. Approximately 90% of these are differentiated thyroid carcinomas (DTC) with a favorable prognosis and cure rate. DTC has recently witnessed an increase in incidence with a relatively […]